🇺🇸 FDA
Patent

US 10722573

Compositions for stimulation of mammalian innate immune resistance to pathogens

granted A61KA61K2039/54A61K2039/55516

Quick answer

US patent 10722573 (Compositions for stimulation of mammalian innate immune resistance to pathogens) held by The Board of Regents of the University of Texas System expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/54, A61K2039/55516, A61K2039/55561, A61K31/7125